Codexis, Inc.
CDXS
Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protein engineering services. In addition, it offers CodeEvā¦ read more
Healthcare
Biotechnology
15 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$1.66
Price+1.22%
$0.02
1Y
Price
Market Cap
$140.813m
Small
Price/Earnings 3y Avg5y Avg
-
Premium
Premium
Financials Overview
Key metrics over the past few years-189.0%
EBITDA Margin-228.0%
Net Profit Margin-91.7%
Free Cash Flow MarginRevenue
$52.932m
-10.8%
1y CAGR-25.2%
3y CAGR-10.8%
5y CAGREarnings
-$63.951m
+2.0%
1y CAGR-36.8%
3y CAGR-42.1%
5y CAGREPS
-$0.76
+14.6%
1y CAGR-28.1%
3y CAGR-34.7%
5y CAGRBook Value
$38.544m
$123.961m
Assets$85.417m
Liabilities$68.621m
DebtDebt to Assets
55.4%
-1.2x
Debt to EBITDAFree Cash Flow
-$61.661m
-14.8%
1y CAGR-675.2%
3y CAGR-478.7%
5y CAGRFinancial Reports
Earnings and other important metrics. Amounts in USD.No items found.
Press Releases
Statements and updates from the company